Yahoo Finance

Estimated Discount To Fair Value: 17.4%

Vitrolife is trading at SEK208, below its estimated fair value of SEK251.72, suggesting potential undervaluation. Despite a slight decline in third-quarter net income to SEK116 million from SEK122 million the previous year, nine-month earnings improved to SEK374 million. Revenue growth is expected to outpace the Swedish market at 8.3% annually. The company anticipates becoming profitable within three years, although its return on equity is forecasted to remain low at 5.9%.

• Upon reviewing our latest growth report, Vitrolife's projected financial performance appears quite optimistic.

• Dive into the specifics of Vitrolife here with our thorough financial health report.

Zhejiang Juhua

Overview: Zhejiang Juhua Co., Ltd. is engaged in the research, development, production, and sale of chemical raw materials, chemical products, and food additives in China with a market cap of CN¥68.49 billion.

Operations: The company's revenue is primarily derived from the Chemical Industry segment, which generated CN¥22.55 billion.

Estimated Discount To Fair Value: 49.8%

Zhejiang Juhua is trading at CNY 25.37, significantly below its estimated fair value of CNY 50.53, indicating potential undervaluation. For the first nine months of 2024, net income rose to CNY 1.26 billion from CNY 746.78 million a year earlier, with earnings per share also increasing. Revenue growth is forecasted at a moderate pace of 13.4% annually, while earnings are expected to grow substantially by over 39% per year for the next three years.

• Our expertly prepared growth report on Zhejiang Juhua implies its future financial outlook may be stronger than recent results.

• Click here to discover the nuances of Zhejiang Juhua with our detailed financial health report.

Key Takeaways

• Unlock more gems! Our Undervalued Stocks Based On Cash Flows screener has unearthed 874 more companies for you to explore.Click here to unveil our expertly curated list of 877 Undervalued Stocks Based On Cash Flows.

• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.

• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include KOSE:A009540 OM:VITR and SHSE:600160.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com